• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immune dysfunction leads to mortality and organ injury in patients with COVID-19 in China: insights from ERS-COVID-19 study.

作者信息

Li Dongze, Chen You, Liu Hong, Jia Yu, Li Fanghui, Wang Wei, Wu Jiang, Wan Zhi, Cao Yu, Zeng Rui

机构信息

Department of Emergency Medicine and Laboratory of Emergency Medicine, Deep Underground Space Medical Center, Disaster Medical Center, West China School of Nursing, West China Hospital, Sichuan University, Chengdu, China.

Department of Cardiology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.

出版信息

Signal Transduct Target Ther. 2020 May 5;5(1):62. doi: 10.1038/s41392-020-0163-5.

DOI:10.1038/s41392-020-0163-5
PMID:32371949
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7198844/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f73/7200698/33f74e6524f3/41392_2020_163_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f73/7200698/33f74e6524f3/41392_2020_163_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f73/7200698/33f74e6524f3/41392_2020_163_Fig1_HTML.jpg

相似文献

1
Immune dysfunction leads to mortality and organ injury in patients with COVID-19 in China: insights from ERS-COVID-19 study.免疫功能障碍导致中国新冠肺炎患者死亡和器官损伤：ERS-COVID-19研究的见解
Signal Transduct Target Ther. 2020 May 5;5(1):62. doi: 10.1038/s41392-020-0163-5.
2
Simplified immune-dysregulation index: a novel marker predicts 28-day mortality of intensive care patients with COVID-19.简化免疫失调指数：一种新型标志物可预测 COVID-19 重症监护患者的 28 天死亡率。
Intensive Care Med. 2020 Aug;46(8):1645-1647. doi: 10.1007/s00134-020-06114-2. Epub 2020 May 20.
3
Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.71 例 COVID-19 患者的临床特征和免疫损伤机制。
mSphere. 2020 Jul 15;5(4):e00362-20. doi: 10.1128/mSphere.00362-20.
4
Clonal haematopoiesis and COVID-19: A possible deadly liaison.克隆性造血与 COVID-19：可能致命的关联
Int J Immunogenet. 2020 Aug;47(4):329-331. doi: 10.1111/iji.12503. Epub 2020 Jun 8.
5
Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19.概述：由 SARS-CoV-2 感染引起的肺损伤导致的全身炎症反应解释了 COVID-19 的严重结局。
Front Immunol. 2020 Jun 26;11:1626. doi: 10.3389/fimmu.2020.01626. eCollection 2020.
6
Inside China and COVID-19: Questions and answers.中国与新冠疫情：问答
Travel Med Infect Dis. 2020 Mar-Apr;34:101640. doi: 10.1016/j.tmaid.2020.101640. Epub 2020 Mar 23.
7
IL-6-based mortality risk model for hospitalized patients with COVID-19.基于 IL-6 的 COVID-19 住院患者死亡风险模型。
J Allergy Clin Immunol. 2020 Oct;146(4):799-807.e9. doi: 10.1016/j.jaci.2020.07.009. Epub 2020 Jul 22.
8
COVID-19: immunopathology and its implications for therapy.新型冠状病毒肺炎：免疫病理学及其治疗意义。
Nat Rev Immunol. 2020 May;20(5):269-270. doi: 10.1038/s41577-020-0308-3.
9
Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia.新冠肺炎患者肺炎时外周血中浆母细胞的扩增和记忆 B 细胞的缺失。
Eur J Immunol. 2020 Sep;50(9):1283-1294. doi: 10.1002/eji.202048838. Epub 2020 Aug 13.
10
Dysregulation of type I interferon responses in COVID-19.COVID-19 中 I 型干扰素反应失调。
Nat Rev Immunol. 2020 Jul;20(7):397-398. doi: 10.1038/s41577-020-0346-x. Epub 2020 May 26.

引用本文的文献

1
Vascular fibrosis and extracellular matrix remodelling in post-COVID 19 conditions.新冠后状况下的血管纤维化与细胞外基质重塑
Infect Med (Beijing). 2024 Oct 19;3(4):100147. doi: 10.1016/j.imj.2024.100147. eCollection 2024 Dec.
2
SARS-CoV-2-associated lymphopenia: possible mechanisms and the role of CD147.SARS-CoV-2 相关的淋巴细胞减少症：可能的机制和 CD147 的作用。
Cell Commun Signal. 2024 Jul 4;22(1):349. doi: 10.1186/s12964-024-01718-3.
3
Early Life Stress Is Associated with Alterations in Lymphocyte Subsets Independent of Increased Inflammation in Adolescents.

本文引用的文献

1
Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients.致病性T细胞和炎性单核细胞在重症COVID-19患者中引发炎症风暴。
Natl Sci Rev. 2020 Jun;7(6):998-1002. doi: 10.1093/nsr/nwaa041. Epub 2020 Mar 13.
2
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.中国武汉 2019 年冠状病毒病（COVID-19）患者免疫反应失调。
Clin Infect Dis. 2020 Jul 28;71(15):762-768. doi: 10.1093/cid/ciaa248.
3
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.
早期生活应激与青少年淋巴细胞亚群改变相关，而与炎症增加无关。
Biomolecules. 2024 Feb 22;14(3):262. doi: 10.3390/biom14030262.
4
Immune cells are associated with mortality: the Health and Retirement Study.免疫细胞与死亡率相关：健康与退休研究。
Front Immunol. 2023 Oct 20;14:1280144. doi: 10.3389/fimmu.2023.1280144. eCollection 2023.
5
A brief overview of SARS-CoV-2 infection and its management strategies: a recent update.SARS-CoV-2 感染及其管理策略概述：最新进展。
Mol Cell Biochem. 2024 Sep;479(9):2195-2215. doi: 10.1007/s11010-023-04848-3. Epub 2023 Sep 24.
6
Leukocyte metabolism in obese type 2 diabetic individuals associated with COVID-19 severity.肥胖2型糖尿病个体的白细胞代谢与新冠病毒疾病严重程度相关。
Front Microbiol. 2022 Nov 3;13:1037469. doi: 10.3389/fmicb.2022.1037469. eCollection 2022.
7
Aging, inflammaging and immunosenescence as risk factors of severe COVID-19.衰老、炎症衰老和免疫衰老作为重症 COVID-19 的风险因素。
Immun Ageing. 2022 Nov 11;19(1):53. doi: 10.1186/s12979-022-00309-5.
8
Coronavirus Host Genomics Study: South Africa (COVIGen-SA).冠状病毒宿主基因组研究：南非（COVIGen-SA）。
Glob Health Epidemiol Genom. 2022 Oct 6;2022:7405349. doi: 10.1155/2022/7405349. eCollection 2022.
9
Dysregulation of immunity in COVID-19 and SLE.COVID-19 与系统性红斑狼疮中的免疫失调。
Inflammopharmacology. 2022 Oct;30(5):1517-1531. doi: 10.1007/s10787-022-01047-2. Epub 2022 Aug 26.
10
IL-6 drives T cell death to participate in lymphopenia in COVID-19.IL-6 驱动 T 细胞死亡以参与 COVID-19 中的淋巴细胞减少症。
Int Immunopharmacol. 2022 Oct;111:109132. doi: 10.1016/j.intimp.2022.109132. Epub 2022 Aug 8.
中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征：描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.